


Searching News Database: Lonza Group AG
HSMN NewsFeed - 24 Oct 2006
Cambrex Announces Sale of Bioproducts and Biopharma Subsidiaries to Lonza for $460 Million In Cash
Cambrex Announces Sale of Bioproducts and Biopharma Subsidiaries to Lonza for $460 Million In Cash
